Phase I Chinese PK | NCT00503711 | Trialant

Phase I Chinese PK | NCT00503711 | Trialant

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
100 mg Vandetanib eod	Experimental	100 mg Vandetanib every other day dosing	Drug: Vandetanib
100 mg Vandetanib od	Experimental	100 mg Vandetanib once daily dosing	Drug: Vandetanib
300 mg Vandetanib od	Experimental	300 mg Vandetanib once daily dosing	Drug: Vandetanib 300 mg

Outcomes Module

Contacts/Locations Module

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
21600385	Background	Zhang L, Li S, Zhang Y, Zhan J, Zou BY, Smith R, Martin PD, Jiang Y, Liao H, Guan Z. Pharmacokinetics and tolerability of vandetanib in Chinese patients with solid, malignant tumors: an open-label, phase I, rising multiple-dose study. Clin Ther. 2011 Mar;33(3):315-27. doi: 10.1016/j.clinthera.2011.04.005.